Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument
- PMID: 28952605
- DOI: 10.1038/ejcn.2017.103
Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument
Abstract
In 2013, the American Medical Association (AMA) decided to recognize obesity as a disease. One of the main arguments presented in favor of this was broadly 'utilitarian': the disease label would, it was claimed, provide more benefits than harms and thereby serve the general good. Several individuals and groups have argued that this reasoning is just as powerful in the European context. Drawing mainly on a review of relevant social science research, we discuss the validity of this argument. Our conclusion is that in a Western European welfare state, defining obesity as a disease will not on balance serve the general good, and that it is therefore more appropriate to continue to treat obesity as a risk factor. The main reasons presented in favor of this conclusion are: It is debatable whether a disease label would lead to better access to care and preventive measures and provide better legal protection in Europe. Medicalization and overtreatment are possible negative effects of a disease label. There is no evidence to support the claim that declaring obesity a disease would reduce discrimination or stigmatization. In fact, the contrary is more likely, since a disease label would categorically define the obese body as deviant.
Similar articles
-
The medicalization of obesity, bariatric surgery, and population health.Health (London). 2017 Sep;21(5):498-518. doi: 10.1177/1363459316660858. Epub 2016 Aug 16. Health (London). 2017. PMID: 27531066
-
[The origin of informed consent].Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Acta Otorhinolaryngol Ital. 2005. PMID: 16602332 Italian.
-
Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.Psychol Sci Public Interest. 2011 Jan;12(1):3-54. doi: 10.1177/1529100611418056. Psychol Sci Public Interest. 2011. PMID: 26168418
-
[Neuroscience in the Courtroom: From responsibility to dangerousness, ethical issues raised by the new French law].Encephale. 2015 Oct;41(5):385-93. doi: 10.1016/j.encep.2014.08.014. Epub 2014 Oct 27. Encephale. 2015. PMID: 25439859 Review. French.
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
Cited by
-
COVID-19: Is there a role for immunonutrition in obese patient?J Transl Med. 2020 Nov 7;18(1):415. doi: 10.1186/s12967-020-02594-4. J Transl Med. 2020. PMID: 33160363 Free PMC article. Review.
-
Metabolically Healthy Obesity.Endocr Rev. 2020 May 1;41(3):bnaa004. doi: 10.1210/endrev/bnaa004. Endocr Rev. 2020. PMID: 32128581 Free PMC article. Review.
-
Definition and diagnostic criteria of clinical obesity.Lancet Diabetes Endocrinol. 2025 Mar;13(3):221-262. doi: 10.1016/S2213-8587(24)00316-4. Epub 2025 Jan 14. Lancet Diabetes Endocrinol. 2025. PMID: 39824205 Review.
-
Global prevalence of obesity and overweight among medical students: a systematic review and meta-analysis.BMC Public Health. 2024 Jun 24;24(1):1673. doi: 10.1186/s12889-024-19184-4. BMC Public Health. 2024. PMID: 38915047 Free PMC article.
-
Nurses' Role in Obesity Management in Adults in Primary Healthcare Settings Worldwide: A Scoping Review.Healthcare (Basel). 2024 Aug 26;12(17):1700. doi: 10.3390/healthcare12171700. Healthcare (Basel). 2024. PMID: 39273724 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources